Skip to main content

Month: June 2022

FERRARI WILL HOST TODAY ITS CAPITAL MARKETS DAY

Maranello (Italy), June 16, 2022 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) will host today its Capital Markets Day in Maranello (Italy). A live webcast will be available on the Company’s corporate website, commencing today at 9:00 a.m. BST / 10:00 a.m. CEST / 4:00 a.m. EDT. The webcast details and the presentation delivered during the event will be available in the Investors section of the Ferrari corporate website (https://www.ferrari.com/en-EN/corporate/capital-markets-day-2022). For those unable to participate in the live session, a replay will remain archived on the corporate website.AttachmentFNV CMD 2022 Time PR 16.6.22 ENG

Continue reading

AC Immune Provides Update on Alzheimer’s Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer’s Disease

Crenezumab did not statistically significantly slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer’s disease Numerical differences favouring crenezumab over placebo were observed across the co-primary, multiple secondary and exploratory endpoints Initial data will be presented at the Alzheimer’s Association International Conference (AAIC) on August 2, 2022 LAUSANNE, Switzerland, June 16, 2022 (GLOBE NEWSWIRE) — AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced results from the Alzheimer’s Prevention Initiative (API) Autosomal Dominant Alzheimer’s Disease (ADAD) Colombia Trial. The study evaluated the potential of crenezumab, an investigational medicine, to slow...

Continue reading

Hexagon Purus receives follow-on order for hydrogen distribution systems from PAK PCE BIOPALIWA I WODÓR

Hexagon Purus, through its wholly owned subsidiary Wystrach GmbH (“Wystrach”), has received a follow-on order for hydrogen distribution systems from PAK PCE BIOPALIWA I WODÓR (“PAC PCE”), a company owned by ZE PAK, Poland’s largest privately owned electricity producer. ZE PAK and GRUPA POLSAT PLUS are strategically investing in hydrogen activities across the industrial and mobility sectors with the aim to contribute to their joint strategy to accelerate the ongoing green shift in Poland, where hydrogen will play an integral part to decarbonize “hard to abate” sectors. The follow-on order can be viewed in conjunction with the announcement in Hexagon Purus’ Q4 2021 presentation for hydrogen distribution systems and mobile hydrogen refueling stations. The value of the follow-on order is approximately EUR 3.5 million (approximately NOK 36...

Continue reading

Hexagon Purus receives follow-on order for hydrogen distribution systems from PAK PCE BIOPALIWA I WODÓR

Hexagon Purus, through its wholly owned subsidiary Wystrach GmbH (“Wystrach”), has received a follow-on order for hydrogen distribution systems from PAK PCE BIOPALIWA I WODÓR (“PAC PCE”), a company owned by ZE PAK, Poland’s largest privately owned electricity producer. ZE PAK and GRUPA POLSAT PLUS are strategically investing in hydrogen activities across the industrial and mobility sectors with the aim to contribute to their joint strategy to accelerate the ongoing green shift in Poland, where hydrogen will play an integral part to decarbonize “hard to abate” sectors. The follow-on order can be viewed in conjunction with the announcement in Hexagon Purus’ Q4 2021 presentation for hydrogen distribution systems and mobile hydrogen refueling stations. The value of the follow-on order is approximately EUR 3.5 million (approximately NOK 36...

Continue reading

Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease

Crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer’s disease For more than a decade Roche has been working in collaboration with Banner Alzheimer’s Institute, the University of Antioquia in Colombia and the National Institute on Aging on this pioneering prevention study Initial data will be presented at the upcoming Alzheimer’s Association International ConferenceBasel, 16 June 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY), together with Banner Alzheimer’s Institute, today announced results from the Alzheimer’s Prevention Initiative (API) Autosomal Dominant Alzheimer’s Disease (ADAD) Colombia Trial. The study evaluated the potential of crenezumab, an investigational medicine, to slow or prevent Alzheimer’s disease in cognitively unimpaired...

Continue reading

TGS Announces the World’s First Multi-Client Offshore Wind Measurement Campaign

OSLO, Norway (16 June 2022) – TGS, a global energy data and intelligence provider, announced the start of the world’s first multi-client offshore wind measurement campaign today. The project will enhance and further validate TGS’ expansive high-resolution coverage of numerical weather prediction (NWP) model data by including highly sought-after floating LiDAR wind measurements in the New York Bight area off the US East Coast. This unique combination of trusted wind resource models and real measurements will enable the most accurate forecasting of the wind energy potential in the area. The multi-client approach offers offshore wind stakeholders the added benefits of reduced development costs and timelines, as the TGS-deployed floating LiDAR will provide data and insights on a subscription basis to many customers within the region...

Continue reading

POWERING UP REXEL

POWERING UP REXEL:Upwards revision of 2022 guidanceNew medium-term roadmap, profitable growth ambitions and ESG targetspresented at Capital Markets Day Rexel is hosting today from 1 PM CEST a Capital Markets Day at its Swiss headquarters in Zürich. During the event, it will present its new medium-term roadmap and unveil its upgraded 2022 financial targets as well as its 2022-2025 ambitions. After undergoing a profound transformation over the past five years that has enhanced the Group’s resilience, Rexel is now well positioned for a new phase of profitable growth, driven both by further optimization of its core model and the development of a leadership position on topics shaping the future of the industry: ESG, energy transition solutions and advanced services. These are encapsulated in a new company-wide plan called Power Up 2025 and...

Continue reading

New research reveals the critical actions needed to ensure COVID-19-driven surge in virtual health and care drives health access and equity

COVID-19 pandemic triggered a massive surge in virtual health and care delivery across the world, with many countries embracing hybrid virtual and in-person servicesReport from the Broadband Commission for Sustainable Development Working Group on Virtual Health and Care – co-chaired by the World Health Organization and the Novartis Foundation – provides learnings from 23 countriesThe report calls on health decision makers to act to prevent digital divides from increasing health inequities: countries need to implement clear policies that ensure equitable and inclusive access to virtual services for entire populationsBasel, June 16, 2022 — Many unnecessary restrictions on virtual health and care were swept away by the pandemic, and most people have embraced this new world of virtual care, according to a new report from a Broadband...

Continue reading

Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options

Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by infection with Human Papillomavirus (HPV). 1 Nearly nine out of 10 women who die from cervical cancer live in low- and middle-income countries.2 For patients living in areas with limited healthcare resources, increasing access to screening and decreasing barriers to sample collection are keys to ultimately preventing this disease. Roche’s HPV self sampling solution expands access to HPV screening options by enabling patients to privately collect their sample while at a healthcare facility.Basel, 16 June 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of a human papillomavirus (HPV) self sampling solution in countries accepting the CE mark. This new solution enables...

Continue reading

Dassault Systèmes’ Capital Markets Day: On Trajectory to Achieve 2024 Objectives, Outlining Long-Term Growth Opportunities

Press ReleaseVELIZY-VILLACOUBLAY — June 16, 2022 Dassault Systèmes’ Capital Markets Day: On Trajectory to Achieve 2024 Objectives, Outlining Long-Term Growth Opportunities Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) will host its 2022 Capital Markets Day at the company’s headquarters in Vélizy-Villacoublay, France, today, June 16, 2022. The event, dedicated to financial analysts and shareholders, includes a series of presentations by Dassault Systèmes’ Executive Management to discuss the firm’s business, strategy and objectives: the company is on the trajectory to achieve its 2024 non-IFRS EPS objective and is well positioned to capitalize on significant long-term growth opportunities. Today’s 2022 Capital Markets Day, commencing at 8:00 AM New York time / 2:00 PM Paris time / 1:00 PM London time, will be webcast live and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.